Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
주식 순위 #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
주가
$99.32
시가총액
$48.20B
변동 (1일)
0.98%
변동 (1년)
-32.14%
국가
AU
거래 CSL Limited (CSL)

카테고리

CSL Limited (CSL)의 EPS
December 2025 기준 EPS TTM: $2.98
CSL Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $2.98입니다. 2024년 말에는 회사의 EPS가 $5.47였으며, 이는 2023년의 EPS $4.55와 증가입니다.
CSL Limited의 EPS 기록 (2000 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $2.98 -51.94%
2025 $6.20 13.35%
2024 $5.47 20.22%
2023 $4.55 -31.37%
2022 $6.63 26.05%
2021 $5.26 13.61%
2020 $4.63 9.20%
2019 $4.24 50.89%
2018 $2.81 -4.42%
2017 $2.94 9.29%
2016 $2.69 -7.88%
2015 $2.92 8.15%
2014 $2.70 21.09%
2013 $2.23 12.45%
2012 $1.98 -0.58%
2011 $1.99 49.05%
2010 $1.34 6.70%
2009 $1.25 7.16%
2008 $1.17 64.09%
2007 $0.71 500.34%
2006 $0.12 -78.01%
2005 $0.54 168.22%
2004 $0.20 202.40%
2003 $0.07 -21.18%
2002 $0.08 -5.06%
2001 $0.09 83.13%
2000 $0.05 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$3.62 21.55%
DK
$15.47 419.13%
US
$43.12 1,346.98%
US
$9.62 222.85%
BE
$38.32 1,185.91%
NL